Peripheral edema, or swelling of tissues, usually in the lower limbs, due to the accumulation of fluids, was reported in 4.7% of patients given the weight loss drug, Belviq (lorcaserin), versus 2.4% of patients given a placebo according to studies performed leading up to the FDA approval of the drug.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.